What I Learned About GLP-1 Agonists and Self-Harm Risk As a 7-Year Type 2 Diabetes Patient

A person with type 2 diabetes reviewing their medication list with a trusted healthcare provider

Disclaimer: This article is AI-assisted for informational reference only, does not constitute medical advice. Please consult a professional physician before making any decisions.

I was diagnosed with type 2 diabetes at 35, after years of working 60-hour weeks and surviving on takeout and energy drinks. For the first 5 years, metformin worked well enough: my A1c stayed around 7.1, I had minimal side effects, and I thought I had my condition under control. But in 2021, my numbers started creeping up, no matter how strictly I stuck to my low-carb diet and 30-minute daily walks. My endocrinologist suggested I try semaglutide, a GLP-1 receptor agonist, and I jumped at the chance. For the first 3 months, it felt like a miracle: I lost 22 lbs, my A1c dropped to 6.2, and I no longer had constant cravings for sugary snacks. I even stopped needing my daily fast-acting insulin doses for most meals.

But then something shifted. I started having random, uncharacteristic mood swings: I’d snap at my partner for leaving a mug on the counter, or cry for 20 minutes because I burned toast. I brushed it off as work stress, until I started having intrusive thoughts I’d never experienced before: “What if I skip my long-acting insulin tonight and just see what happens?” “What’s the point of sticking to my diet if I’m going to have diabetes forever?” I didn’t connect these thoughts to my medication until last year, when I saw a circulating study examining the Association of GLP-1 receptor agonists with intentional self-harm in patients with type 2 diabetes in my online diabetes support group. I panicked, immediately booked an appointment with my endo, and spent the next three months digging into research, talking to mental health professionals, and connecting with other patients who’d had similar experiences. This is everything I learned, including the mistakes I made and the steps that helped me stay safe while staying on a medication that changed my life.

My Initial GLP-1 Journey: The Wins and the Hidden Pitfall

I went into my GLP-1 prescription only aware of the common side effects everyone talks about: nausea, constipation, occasional acid reflux. My doctor never mentioned anything about mood changes or mental health risks, and I didn’t think to ask – I’d never had depression, anxiety, or any history of mental health struggles, so it never crossed my mind that a diabetes medication could affect my mood.

The Good Parts That Made It Worth It

For the first two months on the 0.25mg and 0.5mg doses, the side effects were mild: I had a little nausea for the first 3 days after each dose increase, but it went away if I ate a small piece of toast before my injection. The benefits far outweighed the discomfort: my energy levels shot up, I no longer needed to nap for 2 hours after work, and my A1c dropped faster than it had in 5 years. I even ran my first 5k that fall, something I never thought I’d be able to do as a type 2 diabetes patient.

The Red Flag I Ignored

When I upped my dose to 1mg, that’s when the mood swings started. At first, I blamed a big project at work, a fight with my sister, and a string of bad sleep. But even after the project ended and things settled down at home, the irritability and intrusive thoughts didn’t go away. I didn’t tell anyone, because I was embarrassed: I thought I was being ungrateful for a medication that was helping my diabetes so much. That was my biggest mistake. By the time I saw that study in my support group, I’d been dealing with those thoughts for almost 6 weeks, and they were getting worse.

Digging Into the Research: What the Association of GLP-1 Receptor Agonists With Intentional Self-Harm in Patients With Type 2 Diabetes Actually Means

I didn’t want to stop taking semaglutide, but I also didn’t want to put my mental health at risk. So I spent 3 weeks reading peer-reviewed papers, talking to my endocrinologist, and connecting with a psychiatrist who specializes in chronic illness patients to separate the clickbait headlines from the actual data.

What the Studies Actually Say (Not What Social Media Claims)

The first thing I learned is that association does not equal causation. The large population studies that first documented the link looked at data from more than 2 million type 2 diabetes patients across Europe and North America. They found that people taking GLP-1 agonists had a 15-20% higher relative risk of intentional self-harm events compared to people taking other common diabetes medications like sulfonylureas. But the absolute risk is extremely low: only 0.3% of GLP-1 users experienced a self-harm event over 2 years, compared to 0.25% of people taking other diabetes meds. That’s a difference of just 5 extra events per 10,000 patients over 2 years.

Researchers still don’t know exactly why the association exists. Some theories suggest that GLP-1 receptors in the brain can affect mood regulation pathways, especially at higher doses. Others note that people prescribed GLP-1s often have more severe type 2 diabetes, which is already linked to higher rates of depression and stress from managing a chronic condition. The constant nausea and fatigue some people experience on higher GLP-1 doses can also worsen mood, even if the medication itself doesn’t directly cause self-harm urges.

Who Is At Higher Risk?

The data shows that the risk is not evenly distributed. People with the highest increased risk include:

Real Cases I’ve Seen (Including My Own)

I’ve talked to more than 30 other type 2 diabetes patients in my support group about this risk over the past year, and I’ve seen both great outcomes and dangerous mistakes. Here are three stories that stand out the most:

  1. My own experience: I told my endocrinologist about my intrusive thoughts during our appointment, and we immediately dropped my semaglutide dose back to 0.5mg. She also referred me to a psychiatrist, who prescribed a low-dose SSRI I took for 6 months. Within 2 weeks of lowering my dose, the intrusive thoughts were gone, and my A1c has stayed at 6.3 for the past year, no higher than it was on the 1mg dose. I’m still on semaglutide today, and I have no mood side effects.
  2. Sarah’s story: Sarah, a 38-year-old type 2 diabetes patient I met in the support group, had a history of postpartum depression 5 years before she started tirzepatide. She disclosed her history to her doctor before starting the medication, and they agreed to check in every 4 weeks to monitor her mood. When she started having mild self-harm urges 2 months in, she told her doctor immediately. They switched her to a shorter-acting GLP-1 (liraglutide) and connected her to weekly talk therapy. She’s now been on liraglutide for 10 months, has no mood symptoms, and her A1c is 6.1.
  3. Mike’s dangerous mistake: Mike, a 52-year-old with no prior mental health history, started having mood swings after upping his semaglutide dose to 1mg. He didn’t tell his doctor, and when he saw the same study I did, he stopped taking the medication cold turkey without talking to anyone. His blood sugar spiked to 380 two days later, and he ended up in the ER with hyperglycemia. He had to stay in the hospital for 2 days to get his levels back under control, and he’s now back on metformin and a sulfonylurea, which don’t control his A1c as well as semaglutide did.

A person tracking their mood and blood sugar levels in a digital journal

My Practical Steps To Stay Safe If You’re On GLP-1s

After my experience and talking to dozens of other patients and providers, I’ve put together a list of 5 simple steps anyone taking or considering GLP-1s can follow to stay safe:

  1. Disclose all mental health history to your prescriber before you start: Even if you had a single bout of depression 10 years ago, or took anxiety meds for a few months in college, tell your doctor. This information helps them monitor you more closely, or choose a lower starting dose if needed.
  2. Track your mood daily for the first 6 months of use or dose increases: I use a free app called Moodfit to log my mood every night, and I write down any intrusive thoughts, irritability, or sadness that lasts more than 2 days. You can also use a plain notebook if you prefer. Bring this log to every doctor’s appointment.
  3. Don’t dismiss small mood changes as “normal stress”: If you’re more irritable than usual, or crying for no reason, or having thoughts that feel out of character, bring it up to your doctor at your next visit, even if you feel embarrassed. These small changes can be early warning signs before more severe symptoms develop.
  4. Never stop taking GLP-1s cold turkey: If you’re experiencing mood symptoms, talk to your doctor first. They can help you taper off the medication slowly if needed, or adjust your dose, to avoid dangerous blood sugar spikes.
  5. Schedule regular mental health check-ins: Even if you have no prior mental health history, schedule a check-in with a primary care provider or therapist every 6 months while you’re on GLP-1s, to talk through any mood changes you might not have noticed.

Common Questions (FAQ)

Q1: Does the documented Association of GLP-1 receptor agonists with intentional self-harm in patients with type 2 diabetes mean these medications cause self-harm?

No. The research only shows a correlation, not a confirmed causal link. It’s possible that other factors, like the stress of managing severe type 2 diabetes or uncomfortable side effects of the medication, are driving the increased risk, rather than the medication itself. More research is still being done to understand the connection.

Q2: I have a history of depression, can I still take GLP-1s?

In most cases, yes. As long as you disclose your full mental health history to your prescriber, and you have regular mood monitoring and mental health support, GLP-1s can be safe for people with prior mental health conditions. Many patients with depression or anxiety take GLP-1s with no mood side effects at all.

Q3: What should I do if I start having intrusive thoughts or self-harm urges after starting a GLP-1?

First, reach out to your prescribing doctor immediately, and be completely honest about exactly what you’re experiencing. If you are in immediate danger, contact a local crisis line or go to the emergency room. Do not stop taking the medication cold turkey, as this can lead to severe blood sugar spikes that can worsen mood symptoms. Your doctor may adjust your dose, switch you to a different medication, or refer you to a mental health professional for support.

Q4: How big is the actual risk of self-harm for people taking GLP-1s?

The absolute risk is extremely low. Less than 1 in 300 people taking GLP-1s for type 2 diabetes experience a self-harm event over 2 years of use, which is only slightly higher than the risk for people taking other common diabetes medications. For most people, the benefits of improved blood sugar control and reduced diabetes complication risk far outweigh the small potential risk.

Final Thoughts

GLP-1 agonists have been life-changing for me, and for millions of other type 2 diabetes patients. But I’ve learned that it’s critical to be aware of all potential risks of any medication you take, not just the benefits that are advertised. I used to think that diabetes medication only affected my blood sugar, but now I know that it can impact every part of my body, including my mood, and being proactive about monitoring my mental health is just as important as checking my blood sugar every morning.

If you want a free 10-page guide that walks you through how to talk to your doctor about GLP-1 risks, track your mood effectively, and prepare for your next endocrinology appointment, you can download it by clicking the link in my profile bio. Thank you for taking the time to read my experience, and I hope it helps you make safe, informed decisions about your own diabetes care.